JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

A8236 Regorafenib

4 Citation

Target: Raf|VEGFR|PDGFR|c-Kit|RET

Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1

≥25.04 mg/mL
A8237 SKLB610

Summary: Potent VEGFR inhibitor

insoluble in H2O; ≥20.75 mg/mL
A8253 PD 173074

Target: VEGFR|FGFR

Summary: FGFR inhibitor

≥26.18 mg/mL
A8255 Sunitinib malate

2 Citation

Target: VEGFR

Summary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor

≥26.65 mg/mL
A2974 Foretinib (GSK1363089)

1 Citation

Summary: VEGF and HGF receptor inhibitor

≥31.65 mg/mL
A2633 Brivanib Alaninate (BMS-582664)

Summary: VEGFR2 inhibitor,ATP-competitive

≥22.05 mg/mL
B7800 BAW2881 (NVP-BAW2881)

Summary: VEGFR inhibitor

≥42.4 mg/mL
B5864 Fruquintinib(HMPL-013)

Target: VEGFR

Summary: Potent and selective inhibitor of VEGFR 1, 2, 3

insoluble in H2O; insoluble in EtOH; ≥6.35 mg/mL
B6746 SU 4312

Summary: VEGFR and PDGFR tyrosine kinases inhibitor

insoluble in H2O; insoluble in EtOH; ≥9.45 mg/mL
B2301 SAR131675

Summary: VEGFR3 inhibitor,selective and ATP-competitve

insoluble in DMSO; insoluble in EtOH; insoluble in H2O